Radiesse in Seoul | CaHA Biostimulator + Hyperdilute Body

Four distinct biostimulator categories. HA filler (Juvéderm Voluma, Restylane Lyft) gives immediate volume only and is fully hyaluronidase-reversible — best for patients who want a trial commitment or reversibility option. Sculptra (PLLA — poly-L-lactic acid) gives no immediate volume but seeds diffuse collagen over 6-12 months across 3-4 sessions — best for global facial rebuilding. JUVELOOK Volume (PDLLA + HA hybrid) gives mild immediate effect plus 6-9 month collagen response — the HA carrier is hyaluronidase-dissolvable, but the PDLLA particles are not. Radiesse gives immediate structural lift (CMC gel) plus 12-18 month collagen scaffold (CaHA microspheres) in one session — best for patients wanting durable contour but accepting non-reversibility. The right choice is a dermatologist's judgment based on your volume loss profile, durability preference, and reversibility comfort.

Hyaluronidase dissolves hyaluronic acid; it has zero effect on calcium hydroxylapatite microspheres. Merz preclinical research (Danysz 2020) tested sodium thiosulfate as a potential reversal agent — STS dissolves CaHA in laboratory conditions but is clinically ineffective for emergency reversal because tissue diffusion is too slow vs vascular ischemia time-course, and STS itself caused tissue necrosis. No FDA-approved Radiesse reversal agent exists in 2026. If you are unhappy with the result, options are limited to massage, intralesional steroid for nodules, intralesional 5-FU + triamcinolone combination for refractory inflammatory nodules, or surgical excision (which scars). This is why we counsel patients explicitly before injection: Radiesse is a 12-18 month commitment.

Lip vermilion is manufacturer-contraindicated by Merz — Jansen 2006 documented a 12.4% nodule rate in lip mucosa with CaHA. The lip mucosa is constantly mobile, contains thin overlying epithelium, and shears the rigid CaHA microspheres into palpable nodules. Glabella and nasal tip are documented high-risk zones for vascular catastrophe (Kapoor 2019 identified Korea as one of the highest filler vision-loss cohorts globally for these zones). Because Radiesse is not hyaluronidase-reversible, the rescue margin if a vascular event occurs is dramatically narrower than with HA filler. For lip enhancement we use HA filler (Juvéderm Volbella, Restylane Kysse) which remains reversible if the result is unsatisfactory.

Honest answer: no. The Lorenc 2022 consensus and Galadari 2024 systematic review are explicit — hyperdilute Radiesse is a skin-quality and laxity protocol, not volumetric augmentation. It improves the surface tightness and crepiness of post-weight-loss buttock and thigh skin, but it does not project volume or reshape silhouette the way fat grafting or true BBL surgery does. If you want a volumetric BBL we refer you to plastic surgery for fat grafting evaluation. If you want skin tightening after GLP-1 or bariatric weight loss, hyperdilute Radiesse across 2-3 monthly sessions is a reasonable choice — the protocol uses Radiesse at 1:1 to 1:6 dilution with saline + lidocaine via 22G blunt cannula fanning in subdermal plane, recruiting fibroblasts to scaffold collagen.

Vascular occlusion — intra-arterial injection causing skin necrosis or, rarely, vision loss. The mechanical risk is the same as any filler, but Radiesse is more dangerous than HA filler because hyaluronidase cannot dissolve the CaHA microspheres and no other proven reversal agent exists. Kapoor 2019 documented Korea as one of the highest filler vision-loss cohorts globally. Our emergency protocol: immediate cessation, warm compress and topical nitroglycerin, collateral hyaluronidase flooding (off-label for CaHA per DeLorenzi 2017 / Cohen consensus — supports vasodilation and dispersion benefit even in pure CaHA cases, and rescues any concurrent HA), aspirin loading, and immediate ophthalmology referral for any visual symptom within the 60-90 minute retinal artery occlusion window. Hyperbaric oxygen (Uittenbogaard 2019) is adjunctive at Seoul tertiary centers (Asan, Samsung, SNU). Vascular occlusion is rare but is treated as a true emergency. We discuss this honestly before injection and provide a 24/7 emergency contact for the first 72 hours.

Day 0 you see immediate volume from the carboxymethylcellulose (CMC) gel carrier plus the microspheres taking space. Weeks 2-3 minor settling begins. Month 1-3 the CMC gel fully resorbs, giving partial softening that worries patients who haven't been counseled. Month 3-6 fibroblasts in direct contact with microspheres upregulate Type I collagen production (Nowag 2022 mechanism — only fibroblasts in direct microsphere contact respond) and elastogenesis begins. Month 6-12 the scaffold and mature collagen produce peak combined effect. Month 12-18 microspheres gradually metabolize to calcium and phosphate ions, results decline, and most patients return for maintenance. Hyperdilute body protocols follow similar timeline but skin-quality improvement (NOT volumetric).

Yes for facial — consultation morning, injection afternoon, 48-hour vascular watch, 3-day window comfortable. Hyperdilute body protocols realistically need 2-3 sessions spaced 4-6 weeks apart, so either plan a longer stay or split across two visits 6-12 weeks apart. Sculptra + Radiesse layered combinations typically require 2-4 weeks between products and are best split across two trips. Maintenance touch-ups at 12-18 months can be performed at your home clinic if competent CaHA injectors are available locally (Merz launched mainland China late 2025; Radiesse is widely available in Tokyo, NYC, Dubai, LA), or you can plan a return visit.

The two biostimulators have complementary collagen mechanisms. Radiesse provides immediate structural lift plus localized Type I collagen scaffolding (per Nowag 2022 — direct fibroblast contact triggers per-cell collagen upregulation). Sculptra (PLLA) provides no immediate volume but seeds diffuse collagen across a broader tissue volume over 6-12 months. Layered, Radiesse builds the architectural foundation (jawline, mid-face) while Sculptra fills the diffuse global rejuvenation gap. Sequencing typically Radiesse first, then Sculptra 2-4 weeks later (or split across two trips). This is a higher-investment protocol reserved for patients with substantial global volume loss who accept multi-month commitment to both products. No published RCT supports the combination; evidence base is expert consensus and case series only — discussed as anecdotal practice at consult.

Three different mechanisms for moderate jowl + chin recession. Radiesse adds projection where bone has remodeled and soft tissue has descended (volume restoration) — a 12-18 month durable structural addition. Ultherapy (HIFU) and Thermage (monopolar RF) tighten existing tissue (no volume added) — best for mild laxity without volume loss. A deep-plane facelift repositions tissue surgically (definitive but invasive, 2-3 weeks downtime, irreversible alteration of anatomy) — for advanced descent that exceeds what volume + tightening can correct. Many adults in their late 50s combine Radiesse + Ultherapy for non-surgical maintenance; facelift becomes the right answer when descent exceeds what volume + tightening can correct. Dr. Yun assesses honestly which bucket you are in at consult — including telling you when you may be at the upper end of what fillers can do.

Possibly. Residual VYCROSS (Juvéderm Voluma's crosslinking technology) can persist in tissue even when visible volume has decreased — recent MRI imaging studies document HA filler persistence beyond clinically visible decline. This matters for two reasons: (a) injection plane selection (we aspirate carefully and use cannula in zones where residual HA may still be present), (b) vascular safety (if a vascular event occurred, we would flood hyaluronidase to dissolve any residual HA contribution even though it cannot dissolve the new Radiesse). Bring records of your prior Tokyo / home-country filler if available. Dr. Yun maps your specific anatomy at consult and may recommend either Radiesse layering on top of residual scaffolding OR another HA filler refresh first depending on what your tissue shows.

Yes — hand dorsum is an FDA-approved indication (PMA P050052/S049 cleared 2015 for diluted CaHA in dorsal hand). Hand dorsum Radiesse restores volume that exposes tendons and veins with age, typically 2 syringes (one per hand) at the first session. Durability on hands is typically 12-15 months (slightly shorter than face due to constant hand use and sun exposure). Cannula technique mandatory for hand dorsum. Pre-treatment ice and elevation reduce bruising. Bruising visible 3-7 days post-injection. Often paired with Lumecca IPL or pico laser for hand dorsum pigmentation correction at the same visit.

Calcium hydroxylapatite is radio-opaque and can appear on facial X-rays, CT scans, mammography, and panoramic dental X-rays. This is benign and well-documented — it is not pathological calcification or cancer. If you undergo any imaging within 24-30 months of Radiesse (microspheres may remain detectable longer than visible clinical correction), inform the radiologist or dentist so they can note the filler in their report and avoid misinterpretation. We provide a written discharge packet that includes treatment date, brand, lot number, and zones — keep this for any future imaging.

Late nodules occur in a small percentage of patients per Hong 2024 Part I early/late nodule classification. Treatment escalation follows a staged protocol: massage and intralesional saline first → oral antibiotics if biofilm/infection suspected → intralesional triamcinolone (10-40 mg/mL diluted) → intralesional 5-FU + triamcinolone combination for refractory inflammatory nodules → surgical excision as last resort (which scars). True granulomatous reaction is rare with CaHA because Lorenc 2022 confirmed no lymphocytic infiltrate in the normal tissue response. Recent dental work, systemic immune events (COVID, severe flu, dental abscess, major surgery), or vaccination are known nodule triggers. Defer Radiesse 2-4 weeks around dental procedures depending on procedure severity.

FDA approvals: PMA P050037 (2006, HIV facial lipoatrophy), P050052 (2006, nasolabial folds), P050052/S049 (2015, hand dorsum diluted CaHA / Radiesse+), and P050052/S129 (2021, jawline contour adults 21+). MFDS Korea approves Radiesse as a Class IV injectable medical device through Merz Aesthetics Korea direct distribution — no third-party import pathway. CE mark under EU MDR. Hyperdilute body application (neck, décolletage, buttock, thigh, hand dorsum diluted) is off-label per Goldie 2018 global expert consensus. We disclose the off-label nature of hyperdilute use in writing at consent.

Yes to both. Pre-trip virtual consultation is available before flight booking — submit intake form with concern photos and brief history; Dr. Yun reviews and we email a per-session quote schedule plus 3-track treatment plan recommendation before you commit to travel. Languages supported: Korean / English / Japanese / Mandarin Chinese / Vietnamese / Thai / Arabic via clinic translator or pre-trip messenger (KakaoTalk / LINE / Zalo / WhatsApp / WeChat). Japanese and Mandarin typically same-week availability; Arabic, Vietnamese, Thai prefer 1-2 week lead time. English is fluent at all consults. Pre-trip messenger follow-up at 1-week, 4-week, and 12-week post-injection in your language is included.

Because the safety margin in non-reversible biostimulator injection for Asian skin lives in parameter individualization — anatomy-based product selection (Radiesse vs Sculptra vs HA filler is a YMYL-grade decision), cannula-first technique in vascular-risk zones, aspiration discipline at every bolus, real-time vascular monitoring, and the willingness to refuse a course (decline at consult) rather than chase a sale. Korean specialist requirement for clinic naming is a clinic-naming rule, not a statutory device-operation gate. We position a Board-Certified dermatologist at the planning and review of every Radiesse session as a clinical-quality choice, not as a legal claim. Factory-style high-volume biostimulator injection is how operator-dependent complications (lip nodules from off-label injection, vascular catastrophe from glabella injection, late granulomas from over-treatment) accumulate; small-practice discipline is how they do not.

If you have never had filler before, want to test how filler suits you, or have any reservation about commitment, HA filler is the conservative first choice — it is reversible and forgiving. If you have already had HA filler, like the result, and want longer durability with added biostimulation, Radiesse is a reasonable next step. If you have substantial global volume loss and want a 12-18 month plus collagen-rebuild commitment, Radiesse (alone or layered with Sculptra) is well-suited. We never start a first-ever filler patient on Radiesse without explicit non-reversibility counsel.